Hello, Guest
Login
Sign Up
 
 

Research In Motion Limited (USA) (NASDAQ:RIMM) Is Showing Selling Pressure - VPRT, The Chubb Corporation, PKI

 
 
Repost This

Lakeway, NY -- (SBWIRE) -- 02/01/2013 -- A rash of negative commentary helped Research In Motion Limited (USA)(NASDAQ:RIMM) close with big losses again; shares are now down 26% on the week. Evercore joined Credit Suisse in downgrading BlackBerry, citing steep unsubsidized pricing and limited initial availability for the Z10, and a lack of timing details about the QWERTY-featuring Q10. Canaccord and MKM are also downbeat on BB10's prospects, and shots have been fired at the Z10's low-light camera performance and (Bing-powered) mapping software. Goldman, which upgraded in November, is staying positive.

How Should Investors Trade RIMM After The Recent Turmoil? Get Special Trend Analysis Coverage Here

VistaPrint Limited(NASDAQ:VPRT): FQ2 easily beats across the board on a double-digit gain in total revenue. Net income grew by 14% Y/Y due largely to seasonal strength of its holiday-related business in Europe. Gross margin also grew to 67.2% from 66.8%. The company ups EPS guidance for FY 2013, now expecting an EPS of $1.79 to $1.99 per share. The Street view is for earnings of $1.74 per share. However, revenue is expected to be on the low end of estimates. Shares of VPRT slid 2%.

Is VPRT a Buy After The Recent Earnings Report? Don’t Miss our Special Coverage Here

The Chubb Corporation(NYSE:CB) Beats on Q4 earnings expectations, but net earnings decline 77% Y/Y as hefty costs related to Hurricane Sandy weighed on results. Despite Sandy, operating profit rose and the company provided upbeat earnings guidance for the current year, now forecasting FY13 operating income of $6.40 to $6.80 per share, above the $6.26 estimate from Street analysts. The company also authorized a $1.3B stock buyback.

Get Latest News, Free Trend Analysis On CB Here

PerkinElmer, Inc.(NYSE:PKI)’s Q4 EPS comes in line with estimates. Net losses narrowed on higher organic revenue plus an income-tax benefit. Human health segment revenue improved 6.5%. For FY13, the company forecast earnings of $2.24 to $2.32 a share, on organic revenue growth in the mid-single-digit range. Street expectations are for $2.32 per a share and growth of 4.8%.

Is PKI a Buy After The Solid Earnings? Find Out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.